These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9121768

  • 21. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 22. The E2F1-3 transcription factors are essential for cellular proliferation.
    Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G.
    Nature; 2001 Nov 22; 414(6862):457-62. PubMed ID: 11719808
    [Abstract] [Full Text] [Related]

  • 23. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B, Farmer AA, Lee WH.
    Cell Growth Differ; 1996 Jun 22; 7(6):689-97. PubMed ID: 8780882
    [Abstract] [Full Text] [Related]

  • 24. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ, Schaley JE, Feeney G, Hearing P.
    Oncogene; 2001 Apr 05; 20(15):1882-91. PubMed ID: 11313936
    [Abstract] [Full Text] [Related]

  • 25. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts.
    Kim H, You S, Kim IJ, Foster LK, Farris J, Ambady S, Ponce de León FA, Foster DN.
    Oncogene; 2001 May 10; 20(21):2671-82. PubMed ID: 11420679
    [Abstract] [Full Text] [Related]

  • 26. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 27. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K.
    Oncogene; 1999 Nov 04; 18(46):6398-402. PubMed ID: 10597240
    [Abstract] [Full Text] [Related]

  • 28. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A.
    Cell Death Differ; 1998 May 04; 5(5):381-9. PubMed ID: 10200487
    [Abstract] [Full Text] [Related]

  • 29. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M.
    Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422
    [Abstract] [Full Text] [Related]

  • 30. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
    Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, Nojima H.
    Oncogene; 1999 Apr 08; 18(14):2299-309. PubMed ID: 10327050
    [Abstract] [Full Text] [Related]

  • 31. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M.
    Clin Cancer Res; 2000 Jul 08; 6(7):2851-9. PubMed ID: 10914734
    [Abstract] [Full Text] [Related]

  • 32. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P, Raj GV, Kundu M, Khalili K, Amini S.
    Oncogene; 1997 Jun 19; 14(24):2959-69. PubMed ID: 9205103
    [Abstract] [Full Text] [Related]

  • 33. p27kip1-independent cell cycle regulation by MYC.
    Berns K, Martins C, Dannenberg JH, Berns A, te Riele H, Bernards R.
    Oncogene; 2000 Oct 05; 19(42):4822-7. PubMed ID: 11039898
    [Abstract] [Full Text] [Related]

  • 34. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.
    Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753
    [Abstract] [Full Text] [Related]

  • 35. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X, Cress WD, Zhong Q, Zuckerman KS.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):930-9. PubMed ID: 11027571
    [Abstract] [Full Text] [Related]

  • 36. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
    Chew YP, Ellis M, Wilkie S, Mittnacht S.
    Oncogene; 1998 Oct 29; 17(17):2177-86. PubMed ID: 9811449
    [Abstract] [Full Text] [Related]

  • 37. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL.
    Cancer Gene Ther; 1999 Oct 29; 6(2):163-71. PubMed ID: 10195883
    [Abstract] [Full Text] [Related]

  • 38. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
    Johnson DG, Schwarz JK, Cress WD, Nevins JR.
    Nature; 1993 Sep 23; 365(6444):349-52. PubMed ID: 8377827
    [Abstract] [Full Text] [Related]

  • 39. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR, Hromchak R, Mudipalli A, Bloch A.
    Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653
    [Abstract] [Full Text] [Related]

  • 40. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
    Hara E, Uzman JA, Dimri GP, Nehlin JO, Testori A, Campisi J.
    Dev Genet; 1996 Oct 01; 18(2):161-72. PubMed ID: 8934878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.